Hormone Therapy News

Studies reporting on psychological outcomes after growth hormone treatment for short stature in children include a high risk for bias, in part due to a failure to mask participants in most randomized trials and a failure to control for potential confounding factors, according to a systematic review in The Journal of Clinical Endocrinology & Metabolism.

The number of transgender juveniles and young adults seeking hormone therapy has increased sharply in recent years, according to a pair of physicians who are each working toward increasing the amount of data currently available on the subject.

In patients with active acromegaly, cardiomyopathy as assessed through cardiac MRI appears to be less common than once reported, according to recent findings.

In patients with active acromegaly, cardiomyopathy as assessed through cardiac MRI appears to be less common than once reported, according to recent findings.

In ovulating women with obesity, estrogen priming appears to yield improvements in hypothalamic-pituitary-ovarian axis function and proinflammatory profiles, according to recent findings.

Higher levels of estrogen may worsen the effects of type 2 diabetes on the risk for cognitive impairment among older women, according to recent study findings published in Diabetes Care.

One-third of women who take hormones at menopause are using non-FDA-approved compounded drugs, according to a national survey recently published in Menopause, the journal of the North American Menopause Society.

Taking melatonin close to mealtimes may put people with the genetic variant MTNR1B at a greater risk for developing type 2 diabetes, according to recent study findings published in Metabolism.

Hormone therapy is effective for most women aged up to 60 years or less than 10 years past the onset of menopause who experience bothersome hot flashes and other menopause-related symptoms, according to a clinical practice guideline released by the Endocrine Society.

Since South Carolina began providing additional payment for the insertion of long-acting reversible contraceptives immediately following delivery in 2012, at least 14 other Medicaid agencies have implemented similar policies, according to recently published data.